Medroxyprogesterone: increased risk of cervical infections

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2004

Schlagwörter:	Cohort Study Independent Risk Factor Prospective Cohort Oral Contraceptive Prospective Cohort Study

Anmerkung:	© Adis International Ltd 2004

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1460(2004), 1 vom: Okt., Seite 20-20
Übergeordnetes Werk:	volume:1460 ; year:2004 ; number:1 ; month:10 ; pages:20-20

Links:	Volltext

DOI / URN:	10.2165/00128413-200414600-00049

Katalog-ID:	SPR03520124X

Internformat


LEADER	01000caa a22002652 4500
001	SPR03520124X
003	DE-627
005	20230519215347.0
007	cr uuu---uuuuu
008	201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200414600-00049 \|2 doi
035			\|a (DE-627)SPR03520124X
035			\|a (SPR)00128413-200414600-00049-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Medroxyprogesterone: increased risk of cervical infections
264		1	\|c 2004
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2004
650		4	\|a Cohort Study \|7 (dpeaa)DE-He213
650		4	\|a Independent Risk Factor \|7 (dpeaa)DE-He213
650		4	\|a Prospective Cohort \|7 (dpeaa)DE-He213
650		4	\|a Oral Contraceptive \|7 (dpeaa)DE-He213
650		4	\|a Prospective Cohort Study \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1460(2004), 1 vom: Okt., Seite 20-20 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1460 \|g year:2004 \|g number:1 \|g month:10 \|g pages:20-20
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200414600-00049 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1460 \|j 2004 \|e 1 \|c 10 \|h 20-20

Indexfelder

matchkey_str	article:22306056:2004----::erxpoetrnicesdikfev
hierarchy_sort_str	2004
publishDate	2004
allfields	10.2165/00128413-200414600-00049 doi (DE-627)SPR03520124X (SPR)00128413-200414600-00049-e DE-627 ger DE-627 rakwb eng Medroxyprogesterone: increased risk of cervical infections 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Cohort Study (dpeaa)DE-He213 Independent Risk Factor (dpeaa)DE-He213 Prospective Cohort (dpeaa)DE-He213 Oral Contraceptive (dpeaa)DE-He213 Prospective Cohort Study (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1460(2004), 1 vom: Okt., Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1460 year:2004 number:1 month:10 pages:20-20 https://dx.doi.org/10.2165/00128413-200414600-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1460 2004 1 10 20-20
spelling	10.2165/00128413-200414600-00049 doi (DE-627)SPR03520124X (SPR)00128413-200414600-00049-e DE-627 ger DE-627 rakwb eng Medroxyprogesterone: increased risk of cervical infections 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Cohort Study (dpeaa)DE-He213 Independent Risk Factor (dpeaa)DE-He213 Prospective Cohort (dpeaa)DE-He213 Oral Contraceptive (dpeaa)DE-He213 Prospective Cohort Study (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1460(2004), 1 vom: Okt., Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1460 year:2004 number:1 month:10 pages:20-20 https://dx.doi.org/10.2165/00128413-200414600-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1460 2004 1 10 20-20
allfields_unstemmed	10.2165/00128413-200414600-00049 doi (DE-627)SPR03520124X (SPR)00128413-200414600-00049-e DE-627 ger DE-627 rakwb eng Medroxyprogesterone: increased risk of cervical infections 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Cohort Study (dpeaa)DE-He213 Independent Risk Factor (dpeaa)DE-He213 Prospective Cohort (dpeaa)DE-He213 Oral Contraceptive (dpeaa)DE-He213 Prospective Cohort Study (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1460(2004), 1 vom: Okt., Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1460 year:2004 number:1 month:10 pages:20-20 https://dx.doi.org/10.2165/00128413-200414600-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1460 2004 1 10 20-20
allfieldsGer	10.2165/00128413-200414600-00049 doi (DE-627)SPR03520124X (SPR)00128413-200414600-00049-e DE-627 ger DE-627 rakwb eng Medroxyprogesterone: increased risk of cervical infections 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Cohort Study (dpeaa)DE-He213 Independent Risk Factor (dpeaa)DE-He213 Prospective Cohort (dpeaa)DE-He213 Oral Contraceptive (dpeaa)DE-He213 Prospective Cohort Study (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1460(2004), 1 vom: Okt., Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1460 year:2004 number:1 month:10 pages:20-20 https://dx.doi.org/10.2165/00128413-200414600-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1460 2004 1 10 20-20
allfieldsSound	10.2165/00128413-200414600-00049 doi (DE-627)SPR03520124X (SPR)00128413-200414600-00049-e DE-627 ger DE-627 rakwb eng Medroxyprogesterone: increased risk of cervical infections 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Cohort Study (dpeaa)DE-He213 Independent Risk Factor (dpeaa)DE-He213 Prospective Cohort (dpeaa)DE-He213 Oral Contraceptive (dpeaa)DE-He213 Prospective Cohort Study (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1460(2004), 1 vom: Okt., Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1460 year:2004 number:1 month:10 pages:20-20 https://dx.doi.org/10.2165/00128413-200414600-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1460 2004 1 10 20-20
language	English
source	Enthalten in Inpharma weekly 1460(2004), 1 vom: Okt., Seite 20-20 volume:1460 year:2004 number:1 month:10 pages:20-20
sourceStr	Enthalten in Inpharma weekly 1460(2004), 1 vom: Okt., Seite 20-20 volume:1460 year:2004 number:1 month:10 pages:20-20
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Cohort Study Independent Risk Factor Prospective Cohort Oral Contraceptive Prospective Cohort Study
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2004-10-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR03520124X
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03520124X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519215347.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414600-00049</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03520124X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414600-00049-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Medroxyprogesterone: increased risk of cervical infections</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cohort Study</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Independent Risk Factor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prospective Cohort</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral Contraceptive</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prospective Cohort Study</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1460(2004), 1 vom: Okt., Seite 20-20</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1460</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:20-20</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414600-00049</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1460</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">20-20</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Medroxyprogesterone: increased risk of cervical infections Cohort Study (dpeaa)DE-He213 Independent Risk Factor (dpeaa)DE-He213 Prospective Cohort (dpeaa)DE-He213 Oral Contraceptive (dpeaa)DE-He213 Prospective Cohort Study (dpeaa)DE-He213
topic	misc Cohort Study misc Independent Risk Factor misc Prospective Cohort misc Oral Contraceptive misc Prospective Cohort Study
spellingShingle	misc Cohort Study misc Independent Risk Factor misc Prospective Cohort misc Oral Contraceptive misc Prospective Cohort Study Medroxyprogesterone: increased risk of cervical infections
topic_unstemmed	misc Cohort Study misc Independent Risk Factor misc Prospective Cohort misc Oral Contraceptive misc Prospective Cohort Study
topic_browse	misc Cohort Study misc Independent Risk Factor misc Prospective Cohort misc Oral Contraceptive misc Prospective Cohort Study
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Medroxyprogesterone: increased risk of cervical infections
ctrlnum	(DE-627)SPR03520124X (SPR)00128413-200414600-00049-e
title_full	Medroxyprogesterone: increased risk of cervical infections
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2004
contenttype_str_mv	txt
container_start_page	20
container_volume	1460
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200414600-00049
title_sort	medroxyprogesterone: increased risk of cervical infections
title_auth	Medroxyprogesterone: increased risk of cervical infections
abstract	© Adis International Ltd 2004
abstractGer	© Adis International Ltd 2004
abstract_unstemmed	© Adis International Ltd 2004
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Medroxyprogesterone: increased risk of cervical infections
url	https://dx.doi.org/10.2165/00128413-200414600-00049
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200414600-00049
up_date	2024-07-03T13:51:44.856Z
_version_	1803566139170619392
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03520124X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519215347.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414600-00049</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03520124X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414600-00049-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Medroxyprogesterone: increased risk of cervical infections</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cohort Study</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Independent Risk Factor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prospective Cohort</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral Contraceptive</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prospective Cohort Study</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1460(2004), 1 vom: Okt., Seite 20-20</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1460</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:20-20</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414600-00049</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1460</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">20-20</subfield></datafield></record></collection>
score	7.3999014

Nicht das Richtige dabei?

Schreiben Sie uns!

Medroxyprogesterone: increased risk of cervical infections

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?